Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 10, 2019 Filed Jul 12, 2019 20:27 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 6,834 | $2.90 | $19,818.60 |
DisclosureSEC source: 0001209191-19-041936 · doc4.xml · nonDerivative · entry 1 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,425,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 20:23 UTC |
Chung ChristineSVP, China Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $29.66 | $0.00 |
DisclosureSEC source: 0001209191-19-041933 · doc4.xml · derivative · entry 8 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,959 Underlying: Common Stock · 5,625 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 20:23 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 600 | $45.14 | $27,084.00 |
DisclosureSEC source: 0001209191-19-041933 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,570 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $45.09 to $45.19. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 20:23 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 5,025 | $44.75 | $224,868.75 |
DisclosureSEC source: 0001209191-19-041933 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,170 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $44.09 to $45.08. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 20:23 UTC |
Chung ChristineSVP, China Operations
|
Exercise / conversionCommon Stock | 5,625 | $29.66 | $166,837.50 |
DisclosureSEC source: 0001209191-19-041933 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2019 Filed Jul 11, 2019 00:18 UTC |
Kurkijarvi KaleviDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-19-041757 · doc4.xml · derivative · entry 4 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2021-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| July 08, 2019 Filed Jul 11, 2019 00:18 UTC |
Kurkijarvi KaleviDirector
|
SaleCommon Stock | 1,400 | $43.40 | $60,760.00 |
DisclosureSEC source: 0001209191-19-041757 · doc4.xml · nonDerivative · entry 3 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,400 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $43.13 to $44.07. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 08, 2019 Filed Jul 11, 2019 00:18 UTC |
Kurkijarvi KaleviDirector
|
SaleCommon Stock | 4,600 | $42.35 | $194,810.00 |
DisclosureSEC source: 0001209191-19-041757 · doc4.xml · nonDerivative · entry 2 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,800 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $42.00 to $43.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 08, 2019 Filed Jul 11, 2019 00:18 UTC |
Kurkijarvi KaleviDirector
|
Exercise / conversionCommon Stock | 6,000 | $3.50 | $21,000.00 |
DisclosureSEC source: 0001209191-19-041757 · doc4.xml · nonDerivative · entry 1 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2019 Filed Jul 3, 2019 00:11 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
SaleCommon Stock | 2,873 | $45.00 | $129,285.00 |
DisclosureSEC source: 0001209191-19-040581 · doc4.xml · nonDerivative · entry 1 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,199 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:47 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,834 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-19-038494 · doc4.xml · derivative · entry 12 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,374 Underlying: Common Stock · 6,834 shares Expires 2020-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:47 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 100 | $45.45 | $4,545.00 |
DisclosureSEC source: 0001209191-19-038494 · doc4.xml · nonDerivative · entry 8 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Partnership Disclosed balance after: 55,582 F1 · kind: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:47 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 1,318 | $44.23 | $58,295.14 |
DisclosureSEC source: 0001209191-19-038494 · doc4.xml · nonDerivative · entry 7 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Partnership Disclosed balance after: 55,682 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F6 · price: The shares were sold at prices ranging from $44.02 to $44.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:47 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 2,200 | $45.22 | $99,484.00 |
DisclosureSEC source: 0001209191-19-038494 · doc4.xml · nonDerivative · entry 6 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,419,140 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F5 · price: The shares were sold at prices ranging from $44.92 to $45.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:47 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 16,200 | $44.28 | $717,336.00 |
DisclosureSEC source: 0001209191-19-038494 · doc4.xml · nonDerivative · entry 5 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,421,340 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $43.92 to $44.865. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:47 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 6,834 | $2.90 | $19,818.60 |
DisclosureSEC source: 0001209191-19-038494 · doc4.xml · nonDerivative · entry 4 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,437,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:15 UTC |
Chung ChristineSVP, China Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $29.66 | $0.00 |
DisclosureSEC source: 0001209191-19-038293 · doc4.xml · derivative · entry 6 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,584 Underlying: Common Stock · 5,625 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:15 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 5,625 | $44.02 | $247,612.50 |
DisclosureSEC source: 0001209191-19-038293 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,570 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $43.60 to $44.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:15 UTC |
Chung ChristineSVP, China Operations
|
Exercise / conversionCommon Stock | 5,625 | $29.66 | $166,837.50 |
DisclosureSEC source: 0001209191-19-038293 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:47 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,834 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-19-038494 · doc4.xml · derivative · entry 11 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,208 Underlying: Common Stock · 6,834 shares Expires 2020-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:47 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 1,418 | $43.99 | $62,377.82 |
DisclosureSEC source: 0001209191-19-038494 · doc4.xml · nonDerivative · entry 3 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Partnership Disclosed balance after: 57,000 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $43.695 to $44.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:47 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 18,400 | $44.02 | $809,968.00 |
DisclosureSEC source: 0001209191-19-038494 · doc4.xml · nonDerivative · entry 2 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,430,706 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $43.60 to $44.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:47 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 6,834 | $2.90 | $19,818.60 |
DisclosureSEC source: 0001209191-19-038494 · doc4.xml · nonDerivative · entry 1 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,449,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 22:19 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $14.58 | $0.00 |
DisclosureSEC source: 0001209191-19-038295 · doc4.xml · derivative · entry 2 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,082 Underlying: Common Stock · 16,000 shares Expires 2024-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 22:19 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
Exercise / conversionCommon Stock | 16,000 | $14.58 | $233,200.00 |
DisclosureSEC source: 0001209191-19-038295 · doc4.xml · nonDerivative · entry 1 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 22:18 UTC |
Cotroneo PatSVP, Finance and CFO
|
SaleCommon Stock | 3,201 | $43.12 | $138,027.12 |
DisclosureSEC source: 0001209191-19-038294 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,777 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 22:15 UTC |
Chung ChristineSVP, China Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,120 | $0.00 Strike: $29.66 | $0.00 |
DisclosureSEC source: 0001209191-19-038293 · doc4.xml · derivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,209 Underlying: Common Stock · 2,120 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 22:15 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 5,625 | $44.08 | $247,950.00 |
DisclosureSEC source: 0001209191-19-038293 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,570 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $43.81 to $44.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 22:15 UTC |
Chung ChristineSVP, China Operations
|
Exercise / conversionCommon Stock | 2,120 | $29.66 | $62,879.20 |
DisclosureSEC source: 0001209191-19-038293 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2019 Filed Jun 14, 2019 22:55 UTC |
Yu K PeonyChief Medical Officer
|
SaleCommon Stock | 3,420 | $40.96 | $140,083.20 |
DisclosureSEC source: 0001209191-19-037285 · doc4.xml · nonDerivative · entry 2 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,976 F1 · kind: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 12, 2019 Filed Jun 14, 2019 22:55 UTC |
Yu K PeonyChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,698 | $0.00 Strike: $14.58 | $0.00 |
DisclosureSEC source: 0001209191-19-037285 · doc4.xml · derivative · entry 3 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 657 Underlying: Common Stock · 10,698 shares Expires 2024-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| June 12, 2019 Filed Jun 14, 2019 22:55 UTC |
Yu K PeonyChief Medical Officer
|
Exercise / conversionCommon Stock | 10,698 | $14.58 | $155,923.35 |
DisclosureSEC source: 0001209191-19-037285 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2019 Filed Jun 13, 2019 00:24 UTC |
Blaug SuzanneDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,400 | $0.00 Strike: $39.94 | $0.00 |
DisclosureSEC source: 0001209191-19-036566 · doc4.xml · derivative · entry 3 Blaug Suzanne · CIK 0001778430 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Underlying: Common Stock · 10,400 shares Expires 2029-06-10 F3 · derivative.exercise_date: Option vests quarterly over three years from June 10, 2019. Read SEC document |
| June 10, 2019 Filed Jun 13, 2019 00:24 UTC |
Blaug SuzanneDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,714 | $0.00 Strike: $39.94 | $0.00 |
DisclosureSEC source: 0001209191-19-036566 · doc4.xml · derivative · entry 2 Blaug Suzanne · CIK 0001778430 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,714 Underlying: Common Stock · 7,714 shares Expires 2029-06-10 F2 · derivative.exercise_date: Options vest on the earlier of June 5, 2020 or the date of the next annual meeting of stockholders. Read SEC document |
| June 10, 2019 Filed Jun 13, 2019 00:24 UTC |
Blaug SuzanneDirector
|
GrantCommon Stock | 4,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036566 · doc4.xml · nonDerivative · entry 1 Blaug Suzanne · CIK 0001778430 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,648 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 5, 2020 or the date of the next annual meeting of stockholders. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:39 UTC |
Yu K PeonyChief Medical Officer
|
Tax withholdingCommon Stock | 3,360 | $38.31 | $128,721.60 |
DisclosureSEC source: 0001209191-19-035681 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,698 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 618 shares acquired on May 15, 2019 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:38 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,834 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-19-035680 · doc4.xml · derivative · entry 14 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,042 Underlying: Common Stock · 6,834 shares Expires 2020-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Fully vested. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:38 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 618 | $38.20 | $23,607.60 |
DisclosureSEC source: 0001209191-19-035680 · doc4.xml · nonDerivative · entry 10 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Partnership Disclosed balance after: 58,418 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F9 · price: The shares were sold at prices ranging from $38.155 to $38.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:38 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 800 | $37.77 | $30,216.00 |
DisclosureSEC source: 0001209191-19-035680 · doc4.xml · nonDerivative · entry 9 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Partnership Disclosed balance after: 59,036 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F8 · price: The shares were sold at prices ranging from $37.12 to $38.09. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:38 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 8,542 | $38.31 | $327,244.02 |
DisclosureSEC source: 0001209191-19-035680 · doc4.xml · nonDerivative · entry 8 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,442,272 F7 · kind: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:38 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 11,500 | $38.16 | $438,840.00 |
DisclosureSEC source: 0001209191-19-035680 · doc4.xml · nonDerivative · entry 7 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,450,814 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F6 · price: The shares were sold at prices ranging from $37.945 to $38.49. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:38 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
SaleCommon Stock | 6,900 | $37.57 | $259,233.00 |
DisclosureSEC source: 0001209191-19-035680 · doc4.xml · nonDerivative · entry 6 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,462,314 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F5 · price: The shares were sold at prices ranging from $36.935 to $37.93. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:38 UTC |
Neff Thomas BDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 6,834 | $2.90 | $19,818.60 |
DisclosureSEC source: 0001209191-19-035680 · doc4.xml · nonDerivative · entry 5 Neff Thomas B · CIK 0001623238 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,469,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:36 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
Tax withholdingCommon Stock | 2,058 | $38.31 | $78,841.98 |
DisclosureSEC source: 0001209191-19-035678 · doc4.xml · nonDerivative · entry 1 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,072 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 618 shares acquired on May 15, 2019 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:34 UTC |
Cotroneo PatSVP, Finance and CFO
|
Tax withholdingCommon Stock | 3,144 | $38.31 | $120,446.64 |
DisclosureSEC source: 0001209191-19-035676 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,978 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 618 shares acquired on May 15, 2019 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:33 UTC |
Chung ChristineSVP, China Operations
|
Tax withholdingCommon Stock | 3,480 | $38.31 | $133,318.80 |
DisclosureSEC source: 0001209191-19-035675 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,075 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 618 shares acquired on May 15, 2019 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:16 UTC |
Kurkijarvi KaleviDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-19-035661 · doc4.xml · derivative · entry 6 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2020-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:16 UTC |
Kurkijarvi KaleviDirector
|
SaleCommon Stock | 3,058 | $38.49 | $117,702.42 |
DisclosureSEC source: 0001209191-19-035661 · doc4.xml · nonDerivative · entry 4 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,400 F2 · kind: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $38.18 to $39.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:16 UTC |
Kurkijarvi KaleviDirector
|
SaleCommon Stock | 2,942 | $37.20 | $109,442.40 |
DisclosureSEC source: 0001209191-19-035661 · doc4.xml · nonDerivative · entry 3 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,458 F2 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $37.12 to $38.02. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:16 UTC |
Kurkijarvi KaleviDirector
|
Exercise / conversionCommon Stock | 6,000 | $2.90 | $17,400.00 |
DisclosureSEC source: 0001209191-19-035661 · doc4.xml · nonDerivative · entry 2 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.